Deal Partner

Back to Team

Chris Adams is a Partner with Francisco Partners and focuses primarily on healthcare technology. He has a particular interest in pharmacy and payor related software, information-enabled services, and technology-enabled services businesses.

Prior to joining Francisco Partners in 2008, Chris was with American Securities Capital Partners where he evaluated and executed private equity transactions across business services and industrial technology. Chris previously was a strategy consultant in the Atlanta, Sao Paulo, and Sydney offices of Bain & Company. He has also worked at a venture capital firm in Bangalore and a technology startup in Shanghai.

Chris currently serves on the board of directors of GoodRx, RedSail, and Trellis Rx. He formerly served on a number of boards including Aesynt (acquired by Omnicell), Availity (recapped by financial sponsor), Capsule (acquired by Philips), CoverMyMeds (acquired by McKesson), Landmark Health (acquired by UnitedHealthcare), NexTraq (acquired by Fleetcor), QuadraMed (acquired by Nuance and Constellation Software), Quantros (acquired), and TRC Healthcare (acquired by financial sponsor).


M.B.A. from Stanford Graduate School of Business
B.S. in Computer Engineering from Georgia Institute of Technology, summa cum laude


One Letterman Drive
Building C - Suite 410
San Francisco, CA 94129
Google Maps
“Operating companies require thoughtful leadership and access to resources to be successful. Chris Adams and the rest of the FP team partnered with NexTraq management to identify strategic opportunities, acquire resources and execute our plan to become the market leader in our space.”
Mike Scarborough, CEO, NexTraq